In recent years, Robert Ripley has watched spiking drug prices menace his budget like a fast-rising flood.

The longtime chief of pharmacy for Trinity Health, a Catholic chain of 93 hospitals from New York to California, said he’s never seen anything like it in his 30-plus years in the business. The eye-popping prices of new branded drugs are one issue. But even worse are the wild price hikes and sudden shortages of generics that have been available for many decades.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Yeah, I already subscribe to the Globe, and this is an article in today’s paper. Why should I have to pay again to access it?

  • Congress should pass a law requiring any drug producer that received federal money for research to charge no more in the U S than the lowest price they charge outside the U S.

  • My insurance company is making me discontinue a drug, Gabapentin, Horizant to Gabapentin, Gralise due to price. The new drug didn’t work as well as the old one also.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy